Related Experiment Videos
Directing antigen specificity towards botulinum neurotoxin with combinatorial phage display libraries
P Emanuel1, T O'Brien, J Burans
1Department of Pharmacology and Experimental Therapeutics, School of Medicine, University of Maryland, Baltimore 21201, USA.
Journal of Immunological Methods
|June 21, 1996
Summary
This study demonstrates that recombinant antibody libraries in bacteria efficiently isolate rare antibody specificities, outperforming traditional hybridoma fusions for low immunogenicity antigens like botulinum neurotoxin.
Area of Science:
- Immunology
- Biotechnology
- Molecular Biology
Background:
- Screening antibody combinatorial libraries enhances antibody production against low immunogenicity antigens.
- Isolating rare antibody specificities requires highly efficient screening methods.
- Recombinant immunoglobulin libraries in bacteria offer controlled selection and can isolate rare clones missed by hybridoma fusions.
Purpose of the Study:
- To produce a recombinant antibody library targeting botulinum neurotoxin (NT) and its associated non-neurotoxin proteins (non-NT).
- To compare the efficiency of this library against traditional hybridoma fusions for isolating specific antibody clones.
- To demonstrate the control offered by altering biopanning selection processes.
Main Methods:
- Immunization of mice with a botulinum neurotoxin complex.
- Production of a recombinant antibody library from mouse mRNA.
- Screening of the combinatorial library for antibody specificities.
- Re-screening to isolate antibodies targeting the neurotoxin component.
Main Results:
- Initial screening identified clones recognizing non-neurotoxin proteins, similar to hybridoma-derived monoclonal antibodies.
- Subsequent re-screening successfully isolated antibodies specifically recognizing the neurotoxin component.
- The biopanning selection process allowed for controlled isolation of desired antibody specificities.
Conclusions:
- Recombinant antibody libraries provide a powerful tool for isolating specific antibodies, especially against challenging antigens.
- This method offers superior control over antibody selection compared to conventional hybridoma fusions.
- The approach is effective for generating antibodies targeting specific components of complex toxins.